Cargando…

Exogenous Surfactant May Improve Oxygenation but Not Mortality in Adult Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome: A Meta-Analysis of 9 Clinical Trials

OBJECTIVE: To evaluate whether exogenous surfactant therapy may be useful in adult patients with acute lung injury or acute respiratory distress syndrome, using a meta-analysis of published clinical trials. DESIGN: A comprehensive literature search was performed to identify all randomized clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Haoyu, Sun, Ying, Lu, Jun, Fu, Shukun, Meng, Zhaoyi, Scott, Melanie, Li, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. Published by Elsevier Inc. 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942513/ https://www.ncbi.nlm.nih.gov/pubmed/22265270 http://dx.doi.org/10.1053/j.jvca.2011.11.006

Ejemplares similares

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis
por: ZHANG, LI-NA, et al.
Publicado: (2013)

Efficacy of exogenous surfactant in adult patients with acute respiratory failure
por: Tiruvoipati, R, et al.
Publicado: (2006)

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis
por: Davidson, Warren J, et al.
Publicado: (2006)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis
por: Zhang, Rongyuan, et al.
Publicado: (2020)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

Surfactant protein A: a candidate predictive biomarker of mortality in acute respiratory distress syndrome in sepsis
por: Moroz, V, et al.
Publicado: (2014)

Oxygenation target in acute respiratory distress syndrome
por: Capellier, Gilles, et al.
Publicado: (2023)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia
por: Putz, G., et al.
Publicado: (1996)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
por: Sameed, Muhammad, et al.
Publicado: (2019)

Diagnostic Value of Surfactant Protein-A in Severe Acute Pancreatitis-Induced Acute Respiratory Distress Syndrome
por: Zhu, Bin, et al.
Publicado: (2014)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome
por: DiBlasi, Robert M., et al.
Publicado: (2021)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Extracorporeal membrane oxygenation for acute respiratory distress syndrome
por: Aokage, Toshiyuki, et al.
Publicado: (2015)

The attributable mortality of acute respiratory distress syndrome
por: Auriemma, Catherine L., et al.
Publicado: (2020)

Pulmonary surfactant function in patients with acute lung injury/acute respiratory distress syndrome treated by mechanical ventilation
por: Miller, E, et al.
Publicado: (2005)

Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome
por: Punsawad, Chuchard, et al.
Publicado: (2019)

Dynamic driving pressure associated mortality in acute respiratory distress syndrome with extracorporeal membrane oxygenation
por: Chiu, Li-Chung, et al.
Publicado: (2017)

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome
por: Rizzo, Alicia N., et al.
Publicado: (2022)

Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
por: Meng, Shan-Shan, et al.
Publicado: (2019)

Identification and validation of autophagy‐related genes in exogenous sepsis‐induced acute respiratory distress syndrome
por: Xie, Yongpeng, et al.
Publicado: (2022)

Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome in Adults: Prognostic Factors for Outcomes
por: Wu, Meng-Yu, et al.
Publicado: (2016)

Noninvasive ventilation on mortality of acute respiratory distress syndrome
por: Ye, Ling, et al.
Publicado: (2016)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Increasing Mortality in Venovenous Extracorporeal Membrane Oxygenation for COVID-19–Associated Acute Respiratory Distress Syndrome
por: Braaten, Jacob A., et al.
Publicado: (2022)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study
por: Möller, Jens Christian, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_it9nvcbst6rjaqe9fe1p28h0iu